Response by Aronsen et al to Letter Regarding Article, "Disruption of Phosphodiesterase 3A Binding to SERCA2 Increases SERCA2 Activity and Reduces Mortality in Mice With Chronic Heart Failure"

Circulation. 2023 Sep 5;148(10):857-858. doi: 10.1161/CIRCULATIONAHA.123.065884. Epub 2023 Sep 5.

Authors

Jan Magnus Aronsen^{1

2}, Jonas Skogestad^{1

2}, Ingrid Albert³, Arne Olav Melleby¹, Cathrine R Carlson³

Affiliations

¹ Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Norway (J.M.A., J.S., A.O.M.).
² Department of Pharmacology, Oslo University Hospital, Rikshospitalet, Norway (J.M.A., J.S.).
³ Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Norway (I.A., C.R.C.).

PMID: 37669357
DOI: 10.1161/CIRCULATIONAHA.123.065884

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Chronic Disease
Cyclic Nucleotide Phosphodiesterases, Type 3
Heart Failure*
Mice

Substances

Cyclic Nucleotide Phosphodiesterases, Type 3